The company has reported a fall of 22.67% in its net profit at Rs 100.77 crore for the quarter under review as compared to Rs 130.32 crore for the same quarter in the previous year. Total income from operations of the company marginally decreased by 1.74% at Rs 831.13 crore for Q2FY19 as compared Rs 845.89 crore for the corresponding quarter previous year.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world’s leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.